TG Therapeutics, Inc. (TGTX)
56.05
+1.78
(+3.28%)
USD |
NASDAQ |
Aug 24, 16:00
56.45
+0.40
(+0.71%)
After-Hours: 20:00
TG Therapeutics Total Liabilities (Quarterly) : 1.036B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.036B |
| March 31, 2026 | 945.71M |
| December 31, 2025 | 415.23M |
| September 30, 2025 | 417.81M |
| June 30, 2025 | 426.18M |
| March 31, 2025 | 419.40M |
| December 31, 2024 | 355.33M |
| September 30, 2024 | 393.86M |
| June 30, 2024 | 223.64M |
| March 31, 2024 | 213.21M |
| December 31, 2023 | 169.08M |
| September 30, 2023 | 166.30M |
| June 30, 2023 | 180.40M |
| March 31, 2023 | 169.92M |
| December 31, 2022 | 134.98M |
| September 30, 2022 | 117.41M |
| June 30, 2022 | 122.63M |
| March 31, 2022 | 132.64M |
| December 31, 2021 | 142.48M |
| September 30, 2021 | 98.17M |
| June 30, 2021 | 98.27M |
| March 31, 2021 | 103.41M |
| December 31, 2020 | 106.29M |
| September 30, 2020 | 103.20M |
| June 30, 2020 | 100.39M |
| Date | Value |
|---|---|
| March 31, 2020 | 103.20M |
| December 31, 2019 | 124.40M |
| September 30, 2019 | 119.12M |
| June 30, 2019 | 93.38M |
| March 31, 2019 | 98.28M |
| December 31, 2018 | 59.58M |
| September 30, 2018 | 42.63M |
| June 30, 2018 | 39.34M |
| March 31, 2018 | 35.76M |
| December 31, 2017 | 30.39M |
| September 30, 2017 | 22.24M |
| June 30, 2017 | 23.22M |
| March 31, 2017 | 22.21M |
| December 31, 2016 | 18.91M |
| September 30, 2016 | 18.93M |
| June 30, 2016 | 16.10M |
| March 31, 2016 | 10.62M |
| December 31, 2015 | 11.90M |
| September 30, 2015 | 11.10M |
| June 30, 2015 | 10.66M |
| March 31, 2015 | 11.04M |
| December 31, 2014 | 6.645M |
| September 30, 2014 | 10.46M |
| June 30, 2014 | 4.206M |
| March 31, 2014 | 3.742M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 141.52M |
| MAIA Biotechnology, Inc. | 7.565M |
| Vericel Corp. | 132.82M |
| Incyte Corp. | 1.528B |
| Regeneron Pharmaceuticals, Inc. | 10.02B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.640B |
| Shareholders Equity (Quarterly) | 604.08M |
| Debt to Equity Ratio | 1.249 |
| Current Ratio | 4.267 |
| Net Debt Paydown Yield | -1.19% |